arrow
A

Andréanne Côté

western university (university of western ontario)
H指数:22
被引数:2,334

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study

易得生物制剂与重症哮喘缓解及其他临床结局的关联:一项全球真实世界研究

2026-08-060
OA
Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asthma (HOTHOT)

一项跨国、研究者发起的、平行组、随机、双盲、安慰剂对照的3b期优效性试验方案,评估度普利尤单抗对高风险2型炎症性哮喘诱导临床缓解结局的影响(HOTHOT)

2026-04-110
OAAI
CanMuc: A Canadian consortium-led longitudinal observational study on the role of airway mucus in asthma, chronic obstructive pulmonary disease and chronic cough

CanMuc:一项由加拿大合作组织领导的关于气道黏液在哮喘、慢性阻塞性肺疾病和慢性咳嗽中作用的纵向观察研究

2026-02-010
PRE
Transient Early Blood Eosinophil Increases Do Not Affect Dupilumab's Long-Term Efficacy in Patients with Moderate-to-Severe Asthma

中重度哮喘患者中,短暂的早期血液嗜酸性粒细胞增多不影响Dupilumab的长期疗效。

2025-11-140
PRE
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data

生物制剂启动对口服糖皮质激素使用的影响:国际重症哮喘注册登记研究与国际患者护理研究数据库的真实世界数据合并分析

2025-04-260
OAAI